Axsome Therapeutics to Participate in Upcoming Investor Conferences
Key Highlights
- ➤Axsome (AXSM) to participate in four investor conferences during November 2026
- ➤Guggenheim and UBS conference presentations will offer live webcasts
- ➤Fireside chats scheduled for November 9 and November 16, 2026
- ➤Investor meetings scheduled at Wolfe Research and Truist BioPharma conferences
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in November: * Guggenheim 3rd Annual Healthcare Innovation Conference Fireside Chat: Monday, November 9, 2026, at 11:30 a.m. ET in Boston, MA * 8th Annual Wolfe Research Healthcare Conference Investor Meetings: Tuesday, November 10, 2026, in New York, NY * 2026 Truist BioPharma Symposium Investor Meetings: Thursday, November 12, 2026, in New York, NY * UBS Global Biopharma Conference 2026 Fireside Chat: Monday, November 16, 2026, at 11:20 a.m. GMT in London, England Live webcasts of the Guggenheim and UBS presentations can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at axsome.com. Replays of the webcasts will be available for approximately 30 days following each event.
Get started
Create a free account to read the full story.